First reSept implanted in EU

French TV France3 reported on the first patients implanted with a reSept ASD Occluder in France and in the European Union at Bordeaux University Hospital. The coverage includes video interviews with young patient Léo and his mother, and with the doctors that treated him, as part of the ASCENT ASD trial.

Professor Jean-Benoît Thambo, head of the department of pediatric and congenital cardiology at the Bordeaux University Hospital, said to France3 how “these prostheses are the first phase of the medicine of tomorrow, a medicine that opts for material adapted to the body, biological”.

As interventional cardiologist Zakaria Jalal explained to France3, “with time and healing, the components of the prosthesis will be digested by the body, the patient will eventually carry very few foreign bodies within his body.”

The successful procedure is reported to have lasted for fifteen minutes and that Léo was expected to return home the next day.

The investigational reSept ASD Occluder is also being studied in the US under an FDA approved protocol.

For the English translation, click here

For the original article in French, click here

For the original video interview in French, click here